About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Depression Clinical Trials in New York | 74 Studies

Clinical Trials DepressionNew York

Depression Clinical Trials in New York

Find 74 clinical trials for depression near New York, New York. Connect with research centers in your area.

All Depression trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 74 trials

CompletedA 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDDThis is a 6-month, open-label, flexible-dose study evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in the Treatment of Child and Adolescent Outpatients with Major…NCT01371708·Birmingham, Alabama and 35 others

Depression Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedComparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRDThis is a multi-site, randomized, open-label, effectiveness trial comparing three treatment arms for Major Depressive Disorder (MDD) patients with TRD who are currently on…NCT02977299·Birmingham, Alabama and 12 others

Not yet recruitingUnderstanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal ThoughtsThis study explores how stress, suicidal thoughts, and ketamine's effects are connected in people with major depressive disorder.NCT07139106·New York, New York

CompletedGenetics of Recurrent Early Onset Major DepressionThis study will identify specific genes that may cause a predisposition to depression in some families.NCT00260182·Palo Alto, California and 5 others

CompletedDeveloping New Clinical Management StrategiesThe goal of this study is to develop new methods of administering antidepressant medications that will result in improved drug/placebo separation in randomized controlled trials…NCT02082392·New York, New York

CompletedTranscranial Near Infrared Radiation and Cerebral Blood Flow in DepressionThis study will compare the effect of three transcranial photobiomodulation (t-PBM) doses (high, middle, and low irradiance) to sham t-PBM on PFC CBF as assessed with fMRI (BOLD)…NCT04366258·Charlestown, Massachusetts and 2 others

CompletedStudy of Intravenous NRX-1074 in Patients With Major Depressive DisorderThe purpose of this study is to evaluate the efficacy and safety of NRX-1074 following a single intravenous dose in subjects with major depressive disorder.NCT02067793·Oakland, California and 11 others

CompletedKetamine in the Treatment of Suicidal DepressionThis study is designed to compare the effectiveness of two medications, Ketamine and Midazolam, for rapidly relieving suicidal thoughts in people suffering from depression.NCT01700829·New York, New York

RecruitingPattern Separation in Major Depressive DisorderThis study seeks to examine the effects of treatment with a selective serotonin reuptake inhibitor (SSRI), escitalopram, a first-line treatment for depression, in combination with…NCT07139834·New York, New York

Active not recruitingA Phase 3 Trial of DT120 for Major Depressive Disorder (Emerge)A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Major Depressive Disorder - EmergeNCT06941844·Little Rock, Arkansas and 21 others

CompletedStudy to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for SuicideThe purpose of this study is to assess the efficacy of a single (first) dose of 3 fixed doses of intranasal esketamine {28 milligram (mg), 56 mg, and 84 mg} compared with…NCT03185819·Hartford, Connecticut and 50 others

CompletedRepetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Panic Disorder With Comorbid Major DepressionThis study will evaluate the efficacy of 1-Hz rTMS applied to the right Dorsolateral Prefrontal Cortex (DLPFC) in patients with Panic Disorder (PD) and comorbid Major Depressive…NCT00521352·New York, New York

CompletedEffectiveness of Culturally Based Congruent Care in Treating Hispanics With Major Depressive DisorderThis study will develop and evaluate the effectiveness of a culturally based program that aims to facilitate entry, retention, and successful treatment in specialized mental…NCT00247195·New York, New York

CompletedDoes Dual Therapy Hasten Antidepressant Response?This study will utilize a randomized double-blind design to evaluate whether initial treatment with two anti-depressant medications (escitalopram and bupropion) results in more…NCT00519428·New York, New York and 1 other

CompletedAre Two Antidepressants a Good Initial Treatment for Depression?Relatively drug naive patients will receive two antidepressant medications as initial treatment.NCT00296712·New York, New York

CompletedA Pilot Study Assessing Duloxetine's Efficacy in Atypical DepressionThis is a Pilot Study to get a first indication whether Duloxetine may be effective for depressed patients with Atypical Features.NCT00296699·New York, New York

CompletedThe Effects of the Be Mindful Intervention in Previously Depressed Individuals Experiencing Subclinical SymptomsThis study is designed to help individuals cope with their current depressive symptoms by providing them access to a 4-week online Mindfulness-Based Cognitive Therapy: Be Mindful.NCT04740879·Buffalo, New York

RecruitingA Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderThe purpose of this study is to determine the efficacy, safety and tolerability of CYB003 compared to matching placebo as adjunctive treatment in patients with MDD.NCT06793397·Birmingham, Alabama and 78 others

CompletedProspective Multicenter Trial to Explore the Tolerability and Safety of the H-Coil Deep TMS in Combination With Serotonin Selective Reuptake Inhibitor(SSRI)The purpose of the study is to explore the Tolerability and Safety of the H-Coil deep Transcranial Magnetic Stimulation (TMS) in combination with Serotonin Selective Reuptake…NCT01361815·Davis, California and 18 others

CompletedAntepartum Study on Use of Interpersonal Psychotherapy at 3 New York City SiteThis study will evaluate the effectiveness of interpersonal psychotherapy in treating pregnant women with depression.NCT00251043·New York, New York

PreviousPage 3 of 4Next

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia